Skip to main content

Table 2 Multivariable analyses of the association of risk factors and acute kidney injury (N = 3471)

From: Risk factors for developing acute kidney injury in older people with diabetes and community-acquired pneumonia: a population-based UK cohort study

Characteristics

Model 1 adjusted for age, sex and period OR (95% CI)

P valuea (PT)

Model 4c adjusted for all variables in table except IMD, medications and HBA1C

OR (95% CI)

P valuea (PT)

Model 5 additionally adjusted for medications & HBA1C

OR (95% CI)

P valuea (PT)

Females

 

0.71 (0.56–0.91)

0.007

0.63 (0.48–0.82)

0.0005

0.64 (0.49–0.83)

0.0008

Age years

65–69

0.67 (0.44–1.03)

0.11

0.92 (0.57–1.48)

0.74

0.83 (0.52–1.35)

0.55

70–74

0.62 (0.42–0.92)

 

0.76 (0.50–1.17)

 

0.70 (0.46–1.09)

 

75–79

0.75 (0.53–1.06)

 

0.83 (0.57–1.20)

 

0.78 (0.54–1.13)

 

80–84

0.84 (0.61–1.17)

 

0.88 (0.63–1.24)

 

0.84 (0.59–1.18)

 

≥85

1

 

1

 

1

 

IMDb

1 (least deprived)

1

 

Not in model

 

Not in model

 

2

1.09 (0.74–1.60)

0.96

    

3

1.07 (0.72–1.59)

     

4

1.16 (0.78–1.72)

     

5 (most deprived)

1.06 (0.69–1.61)

     

Smoking status

Non-smoker

1

 

1

 

1

 

Current smoker

1.12 (0.76–1.67)

0.74

1.32 (0.87–2.00)

0.36

1.39 (0.92–2.11)

0.25

Ex-smoker

1.13 (0.83–1.53)

 

1.22 (0.88–1.68)

 

1.26 (0.91–1.74)

 

Alcohol intake (u/day)

Non-drinker

1

 

1

 

1

 

Ex-drinker

0.98 (0.64–1.50)

0.27

1.00 (0.65–1.55)

0.40

1.00 (0.64–1.55)

0.43

Current ≤6 units/day

0.83 (0.59–1.18)

 

0.86 (0.60–1.23)

 

0.88 (0.61–1.26)

 

Heavy >6 units/day

0.52 (0.24–1.15)

 

0.56 (0.25–1.26)

 

0.55 (0.24–1.26)

 

BMI (kg/m2)

15–18.4

0.80 (0.39–1.64)

0.05

0.90 (0.43–1.88)

0.50

0.95 (0.45–2.00)

0.53

18.5–24.9

1

 

1

 

1

 

25–29.9

1.00 (0.74–1.35)

 

0.92 (0.67–1.25)

 

0.90 (0.65–1.23)

 

≥30

1.44 (1.05–1.97)

 

1.17 (0.85–1.62)

 

1.14 (0.82–1.58)

 

eGFR (mL/min/1.73m2)

≤29

5.53 (3.75–8.15)

<0.0001

4.80 (3.18–7.23)

<0.0001

4.62 (3.06–6.99)

<0.0001

30–59

2.74 (2.06–3.66)

(<0.0001)

2.58 (1.92–3.47)

(<0.0001)

2.48 (1.84–3.33)

(<0.0001)

≥60

1

 

1

 

1

 

Proteinuria

1.66 (1.30–2.11)

<0.0001

1.27 (0.98–1.63)

0.07

1.23 (0.95–1.59)

0.12

Hypertension

1.63 (1.21–2.19)

0.0007

1.36 (1.01–1.85)

0.04

1.27 (0.93–1.73)

0.13

Congestive cardiac failure

1.24 (0.94–1.64)

0.13

1.07 (0.79–1.45)

0.65

1.03 (0.76–1.39)

0.86

Ischaemic heart disease

0.90 (0.70–1.15)

0.4

0.79 (0.61–1.03)

0.08

0.76 (0.58–1.00)

0.04

Cerebrovascular diseases

1.00 (0.76–1.31)

0.99

0.90 (0.68–1.19)

0.44

0.90 (0.68–1.20)

0.47

Dementia

1.05 (0.66–1.65)

0.85

1.12 (0.70–1.80)

0.64

1.17 (0.73–1.88)

0.53

Chronic lung disease

0.79 (0.59–1.06)

0.11

0.79 (0.59–1.07)

0.12

0.79 (0.58–1.07)

0.12

Cancer

0.72 (0.52–1.01)

0.05

0.73 (0.52–1.03)

0.07

0.76 (0.54–1.07)

0.11

Connective tissue diseases

0.63 (0.39–1.01)

0.04

0.64 (0.39–1.05)

0.06

0.66 (0.40–1.08)

0.08

Either ACEIs/ ARBs

1.96 (1.49–2.58)

<0.0001

Not in model

 

1.59 (1.19–2.13)

0.002

HBA1C levels

Good <7%

1

 

Not in model

 

1

 

Borderline 7–10%

1.01 (0.79–1.30)

0.98

  

0.82 (0.62–1.09)

0.38

High >7%

0.95 (0.52–1.73)

   

0.82 (0.43–1.54)

 

Medication diabetes

None

1

 

Not in model

 

1

 

Oral

1.10 (0.81–1.50)

0.005

  

1.05 (0.75–1.46)

0.05

Insulin

2.49 (1.46–4.23)

   

2.27 (1.27–4.05)

 

Both

1.43 (0.99–2.07)

   

1.11 (0.72–1.71)

 

Period

April 2004- Sep. 2007

1

<0.0001

1

<0.0001

1

<0.0001

Oct. 2007- March 2011

2.79 (2.07–3.76)

(<0.0001)

2.91 (2.14–3.94)

(<0.0001)

2.90 (2.14–3.95)

(<0.0001)

  1. IMD index of multiple deprivation OR odds ratio CI confidence interval alikelihood ratio test PT P value for trend brecords with missing individual IMD were substituted by values for general practice cModel 2 and 3 are presented in Table 4 in Appendix u units; BMI body mass index, eGFR estimated glomerular filtration rate, ACEI angiotensin converting enzyme inhibitors, ARBs angiotensin II receptor blockers Sep. September Oct. October